DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 15,120
-410 (-2.64%)
At close: Feb 6, 2026
DAE HWA Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 39.72 | 531.42 | -1,147 | 1,116 | 2,217 | -2,008 |
Depreciation & Amortization | 6,077 | 6,405 | 5,871 | 4,541 | 4,818 | 5,668 |
Loss (Gain) From Sale of Assets | - | - | 18.07 | 1.21 | 1.07 | 6.6 |
Asset Writedown & Restructuring Costs | 337 | 337 | 155 | 2,873 | 2,613 | 966.81 |
Loss (Gain) From Sale of Investments | 206.35 | 366.55 | -381.4 | 766.9 | -362.47 | -995.24 |
Loss (Gain) on Equity Investments | - | - | - | - | 212.81 | 206.86 |
Provision & Write-off of Bad Debts | -637.22 | -158.06 | 441.4 | -11.41 | 11.02 | -1,264 |
Other Operating Activities | 3,303 | 3,092 | 1,497 | 570.58 | 393.46 | 3,818 |
Change in Accounts Receivable | -197.97 | 70.05 | -5,406 | -2,433 | -537.21 | 2,554 |
Change in Inventory | 245.97 | -5,043 | -3,845 | -4,861 | 923.27 | -3,031 |
Change in Accounts Payable | -5,242 | -1,628 | 3,339 | 6,482 | 203.78 | -2,178 |
Change in Other Net Operating Assets | 983.14 | 1,277 | -756.71 | -851.72 | -108.88 | -1,091 |
Operating Cash Flow | 5,116 | 5,250 | -214.41 | 8,193 | 10,386 | 2,653 |
Operating Cash Flow Growth | -3.93% | - | - | -21.11% | 291.42% | - |
Capital Expenditures | -3,166 | -4,374 | -8,907 | -27,690 | -9,684 | -3,767 |
Sale of Property, Plant & Equipment | - | - | - | 27.34 | 1.06 | - |
Cash Acquisitions | - | - | - | - | - | -252.56 |
Sale (Purchase) of Intangibles | -1,883 | -1,770 | -2,030 | -4,247 | -4,712 | -6,276 |
Investment in Securities | 4,622 | 10,244 | -4,311 | 6,663 | -3,277 | -1,564 |
Other Investing Activities | 1,148 | 1,170 | 29 | - | 18 | 52 |
Investing Cash Flow | 720.05 | 5,270 | -15,220 | -25,247 | -17,654 | -11,807 |
Short-Term Debt Issued | - | 39,850 | 66,241 | 49,303 | 47,507 | 47,204 |
Long-Term Debt Issued | - | 9,000 | 8,381 | 18,511 | 5,047 | - |
Total Debt Issued | 94,359 | 48,850 | 74,622 | 67,814 | 52,554 | 47,204 |
Short-Term Debt Repaid | - | -55,117 | -52,339 | -46,751 | -31,972 | -33,569 |
Long-Term Debt Repaid | - | -5,042 | -2,013 | -1,403 | -13,735 | -1,263 |
Total Debt Repaid | -100,043 | -60,158 | -54,353 | -48,154 | -45,707 | -34,831 |
Net Debt Issued (Repaid) | -5,684 | -11,308 | 20,270 | 19,660 | 6,848 | 12,373 |
Repurchase of Common Stock | - | - | - | - | - | -165.69 |
Dividends Paid | -2,627 | -2,627 | -2,627 | -2,627 | -2,623 | -2,573 |
Other Financing Activities | 370.12 | -151.19 | -608.05 | -708.67 | 3,573 | -14.71 |
Financing Cash Flow | -7,941 | -14,087 | 17,034 | 16,324 | 7,798 | 9,620 |
Foreign Exchange Rate Adjustments | -367.96 | 876.61 | -375.86 | -147.04 | 61.21 | 247.31 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | - | -0 | - |
Net Cash Flow | -2,474 | -2,691 | 1,224 | -876.6 | 591.24 | 712.9 |
Free Cash Flow | 1,950 | 875.3 | -9,122 | -19,497 | 701.81 | -1,114 |
Free Cash Flow Margin | 1.30% | 0.59% | -6.45% | -14.78% | 0.60% | -1.02% |
Free Cash Flow Per Share | 111.28 | 49.97 | -520.75 | -1113.08 | 40.20 | -64.36 |
Cash Interest Paid | 4,814 | 5,498 | 4,495 | 2,815 | 1,342 | 1,015 |
Cash Income Tax Paid | 200.97 | -307.58 | 280.76 | 2,040 | 1,181 | 5,273 |
Levered Free Cash Flow | -777.51 | -1,953 | -10,874 | -26,251 | -10,965 | -12,018 |
Unlevered Free Cash Flow | 2,272 | 1,458 | -7,953 | -24,773 | -10,016 | -8,639 |
Change in Working Capital | -4,211 | -5,325 | -6,668 | -1,664 | 480.96 | -3,746 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.